1.

Risque à long terme de survenue d'une fracture ostéoporotique en Belgique. ; Long-term risk of osteoporotic fracture in Belgium

2.

Risque à long terme de survenue d'une fracture ostéoporotique en Belgique. ; Long-term risk of osteoporotic fracture in Belgium

3.

Risque à long terme de survenue d'une fracture ostéoporotique en Belgique. ; Long-term risk of osteoporotic fracture in Belgium

4.

Risque à long terme de survenue d'une fracture ostéoporotique en Belgique. ; Long-term risk of osteoporotic fracture in Belgium

5.

Risque à long terme de survenue d'une fracture ostéoporotique en Belgique. ; Long-term risk of osteoporotic fracture in Belgium

6.

Risque à long terme de survenue d'une fracture ostéoporotique en Belgique. ; Long-term risk of osteoporotic fracture in Belgium

7.

Risque à long terme de survenue d'une fracture ostéoporotique en Belgique. ; Long-term risk of osteoporotic fracture in Belgium

8.

Risque à long terme de survenue d'une fracture ostéoporotique en Belgique. ; Long-term risk of osteoporotic fracture in Belgium

9.

Risque à long terme de survenue d'une fracture ostéoporotique en Belgique. ; Long-term risk of osteoporotic fracture in Belgium

1.

Epidémiologie des patients se présentant aux urgences pour dyspnée en Belgique. ; Epidemiology of patients presenting to the emergency room for dyspnea in Belgium.

2.

Epidémiologie des patients se présentant aux urgences pour dyspnée en Belgique. ; Epidemiology of patients presenting to the emergency room for dyspnea in Belgium.

3.

Epidémiologie des patients se présentant aux urgences pour dyspnée en Belgique. ; Epidemiology of patients presenting to the emergency room for dyspnea in Belgium.

4.

Epidémiologie des patients se présentant aux urgences pour dyspnée en Belgique. ; Epidemiology of patients presenting to the emergency room for dyspnea in Belgium.

5.

Epidémiologie des patients se présentant aux urgences pour dyspnée en Belgique. ; Epidemiology of patients presenting to the emergency room for dyspnea in Belgium.

6.

Epidémiologie des patients se présentant aux urgences pour dyspnée en Belgique. ; Epidemiology of patients presenting to the emergency room for dyspnea in Belgium.

7.

Epidémiologie des patients se présentant aux urgences pour dyspnée en Belgique. ; Epidemiology of patients presenting to the emergency room for dyspnea in Belgium.

8.

Epidémiologie des patients se présentant aux urgences pour dyspnée en Belgique. ; Epidemiology of patients presenting to the emergency room for dyspnea in Belgium.

9.

Epidémiologie des patients se présentant aux urgences pour dyspnée en Belgique. ; Epidemiology of patients presenting to the emergency room for dyspnea in Belgium.

1.

Drug utilization review of oral forms of benzodiazepines in a Belgian 635-bed teaching hospital

2.

Drug utilization review of oral forms of benzodiazepines in a Belgian 635-bed teaching hospital

3.

Drug utilization review of oral forms of benzodiazepines in a Belgian 635-bed teaching hospital

4.

Drug utilization review of oral forms of benzodiazepines in a Belgian 635-bed teaching hospital

5.

Drug utilization review of oral forms of benzodiazepines in a Belgian 635-bed teaching hospital

6.

Drug utilization review of oral forms of benzodiazepines in a Belgian 635-bed teaching hospital

7.

Drug utilization review of oral forms of benzodiazepines in a Belgian 635-bed teaching hospital

8.

Drug utilization review of oral forms of benzodiazepines in a Belgian 635-bed teaching hospital

9.

Drug utilization review of oral forms of benzodiazepines in a Belgian 635-bed teaching hospital

1.

Robot-Assisted Radical Hysterectomy in Cervical Carcinoma: The Belgian Experience.

2.

Robot-Assisted Radical Hysterectomy in Cervical Carcinoma: The Belgian Experience.

3.

Robot-Assisted Radical Hysterectomy in Cervical Carcinoma: The Belgian Experience.

4.

Robot-Assisted Radical Hysterectomy in Cervical Carcinoma: The Belgian Experience.

5.

Robot-Assisted Radical Hysterectomy in Cervical Carcinoma: The Belgian Experience.

6.

Robot-Assisted Radical Hysterectomy in Cervical Carcinoma: The Belgian Experience.

7.

Robot-Assisted Radical Hysterectomy in Cervical Carcinoma: The Belgian Experience.

8.

Robot-Assisted Radical Hysterectomy in Cervical Carcinoma: The Belgian Experience.

9.

Robot-Assisted Radical Hysterectomy in Cervical Carcinoma: The Belgian Experience.

1.

Skin cancer screening campaign in the German speaking Community of Belgium.

2.

Skin cancer screening campaign in the German speaking Community of Belgium.

3.

Skin cancer screening campaign in the German speaking Community of Belgium.

4.

Skin cancer screening campaign in the German speaking Community of Belgium.

5.

Skin cancer screening campaign in the German speaking Community of Belgium.

6.

Skin cancer screening campaign in the German speaking Community of Belgium.

7.

Skin cancer screening campaign in the German speaking Community of Belgium.

1.

Aneurysms of the abdominal aorta: familial and genetic aspects in three hundred thirteen pedigrees.

2.

Aneurysms of the abdominal aorta: familial and genetic aspects in three hundred thirteen pedigrees.

3.

Aneurysms of the abdominal aorta: familial and genetic aspects in three hundred thirteen pedigrees.

1.

Robot-assisted surgery for women with endometrial cancer: Surgical and oncologic outcomes within a Belgium gynaecological oncology group cohort.

2.

Robot-assisted surgery for women with endometrial cancer: Surgical and oncologic outcomes within a Belgium gynaecological oncology group cohort.

3.

Robot-assisted surgery for women with endometrial cancer: Surgical and oncologic outcomes within a Belgium gynaecological oncology group cohort.

4.

Robot-assisted surgery for women with endometrial cancer: Surgical and oncologic outcomes within a Belgium gynaecological oncology group cohort.

5.

Robot-assisted surgery for women with endometrial cancer: Surgical and oncologic outcomes within a Belgium gynaecological oncology group cohort.

6.

Robot-assisted surgery for women with endometrial cancer: Surgical and oncologic outcomes within a Belgium gynaecological oncology group cohort.

7.

Robot-assisted surgery for women with endometrial cancer: Surgical and oncologic outcomes within a Belgium gynaecological oncology group cohort.

1.

Increased incidence of sporadic Creutzfeldt-Jakob disease in the age groups between 70 and 90 years in Belgium.

2.

Increased incidence of sporadic Creutzfeldt-Jakob disease in the age groups between 70 and 90 years in Belgium.

3.

Increased incidence of sporadic Creutzfeldt-Jakob disease in the age groups between 70 and 90 years in Belgium.

4.

Increased incidence of sporadic Creutzfeldt-Jakob disease in the age groups between 70 and 90 years in Belgium.

5.

Increased incidence of sporadic Creutzfeldt-Jakob disease in the age groups between 70 and 90 years in Belgium.

6.

Increased incidence of sporadic Creutzfeldt-Jakob disease in the age groups between 70 and 90 years in Belgium.

7.

Increased incidence of sporadic Creutzfeldt-Jakob disease in the age groups between 70 and 90 years in Belgium.

1.

Can predicting COVID-19 mortality in a European cohort using only demographic and comorbidity data surpass age-based prediction: An externally validated study.

2.

Can predicting COVID-19 mortality in a European cohort using only demographic and comorbidity data surpass age-based prediction: An externally validated study.

3.

Can predicting COVID-19 mortality in a European cohort using only demographic and comorbidity data surpass age-based prediction: An externally validated study.

4.

Can predicting COVID-19 mortality in a European cohort using only demographic and comorbidity data surpass age-based prediction: An externally validated study.

5.

Can predicting COVID-19 mortality in a European cohort using only demographic and comorbidity data surpass age-based prediction: An externally validated study.

6.

Can predicting COVID-19 mortality in a European cohort using only demographic and comorbidity data surpass age-based prediction: An externally validated study.

7.

Can predicting COVID-19 mortality in a European cohort using only demographic and comorbidity data surpass age-based prediction: An externally validated study.

1.

The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients.

2.

The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients.

3.

The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients.